In an animal model, pretreatment of silibinin (50, 100, and 200 mg/kg) in kainic acid (KA) - induced status epilepticus (SE) in mice showed a significant neuroprotective effect that might be due to reducing the expression of inflammatory cytokines IL-1β and TNF-α. The gene discussed is TNF; the disease is status epilepticus.